Jocil Ltd Valuation Shifts to Attractive Amid Mixed Market Performance

Valuation Metrics Reflect Renewed Attractiveness

Jocil Ltd’s P/E ratio currently stands at 19.46, a figure that positions it favourably against many of its peers in the Chemicals & Petrochemicals industry. This valuation is particularly compelling when contrasted with companies such as Titan Biotech and Sanstar, which trade at P/E multiples of 68.8 and 94.16 respectively, categorised as very expensive. Even Stallion India, another peer, commands a P/E of 37.39, nearly double that of Jocil.

The company’s price-to-book value ratio of 0.57 further underscores its undervaluation. A P/BV below 1 typically indicates that the stock is trading below its net asset value, which can be attractive for value investors. This contrasts with the sector’s broader valuation landscape, where many peers maintain P/BV ratios closer to or above 1, reflecting higher market confidence or growth expectations.

Other valuation multiples such as EV to EBITDA at 9.17 and EV to EBIT at 16.19 also support the narrative of relative affordability. These multiples are significantly lower than those of Titan Biotech (EV/EBITDA 56.07) and Sanstar (EV/EBITDA 96.29), signalling that Jocil’s enterprise value is more modest relative to its earnings before interest, taxes, depreciation, and amortisation.

Comparative Industry Context and Peer Analysis

Within its peer group, Jocil’s valuation stands out as attractive, especially when juxtaposed with companies like Gulshan Polyols and TGV Sraac, which are rated as very attractive but trade at higher P/E multiples of 28.08 and 9.36 respectively. While TGV Sraac’s lower P/E is notable, Jocil’s PEG ratio of 0.11 is competitive, indicating that its price relative to earnings growth is reasonable. This low PEG ratio suggests that the stock may be undervalued relative to its growth prospects, a key consideration for investors seeking value with growth potential.

However, it is important to note that some peers such as I G Petrochems and Nitta Gelatin are rated as fair, with P/E ratios of 24.55 and 12.15 respectively, and varying EV/EBITDA multiples. This mixed valuation landscape highlights the nuanced positioning of Jocil within the sector, where valuation attractiveness must be balanced against operational and financial performance.

Financial Performance and Returns: A Mixed Picture

Jocil’s recent financial metrics reveal challenges that temper the valuation appeal. The company’s return on capital employed (ROCE) is a modest 0.66%, while return on equity (ROE) stands at 2.92%. These returns are relatively low, signalling limited profitability and efficiency in capital utilisation. Dividend yield is also minimal at 0.37%, offering little income return to shareholders.

From a stock performance perspective, Jocil has underperformed the Sensex over multiple time horizons. Year-to-date, the stock has declined by 6.82%, while the Sensex fell 9.51%, indicating a slightly better relative performance in the short term. However, over one year, Jocil’s stock has dropped 15.72%, significantly worse than the Sensex’s 5.66% decline. The longer-term picture is more concerning, with three-year and five-year returns at -26.47% and -21.68% respectively, compared to Sensex gains of 28.51% and 61.08%. Over a decade, the stock has lost 29.08%, while the Sensex surged 202.54%.

These figures highlight the stock’s struggles to generate sustained shareholder value, despite its current valuation attractiveness. Investors must weigh these performance concerns against the potential for a valuation-driven rebound.

Recent Market Activity and Price Movements

On 18 May 2026, Jocil’s stock closed at ₹135.11, down 0.91% from the previous close of ₹136.35. The day’s trading range was ₹133.60 to ₹138.90, with the 52-week high at ₹177.80 and low at ₹91.25. The current price sits closer to the lower end of the annual range, reinforcing the perception of undervaluation. However, the micro-cap status of the company implies higher volatility and liquidity risks, which investors should consider carefully.

Mojo Score and Rating Update

MarketsMOJO’s latest assessment assigns Jocil a Mojo Score of 48.0, reflecting a cautious stance on the stock. The Mojo Grade has been downgraded from Hold to Sell as of 11 May 2026, signalling increased concerns about the company’s prospects despite its attractive valuation. This downgrade underscores the importance of considering qualitative factors alongside quantitative metrics when evaluating investment opportunities.

Given the micro-cap classification and the company’s modest profitability, the downgrade suggests that risks related to operational performance, market position, or sector dynamics may outweigh the benefits of a low valuation at present.

Investor Takeaway: Valuation Opportunity Amidst Caution

Jocil Ltd’s shift to an attractive valuation grade presents a compelling entry point for value-oriented investors seeking exposure to the Chemicals & Petrochemicals sector. The stock’s P/E and P/BV ratios are notably lower than many peers, and its PEG ratio indicates potential undervaluation relative to growth expectations.

However, the company’s weak returns on capital and equity, combined with a history of underperformance against the Sensex, warrant a cautious approach. The recent downgrade to a Sell rating by MarketsMOJO further emphasises the need for thorough due diligence and risk assessment.

Investors should monitor upcoming financial results and sector developments closely, as any improvement in operational efficiency or profitability could validate the current valuation discount. Conversely, continued underperformance may pressure the stock further despite its low multiples.

Conclusion

Jocil Ltd’s valuation parameters have improved significantly, making it one of the more attractively priced stocks in its sector. Yet, the company’s financial and market performance metrics remain subdued, reflecting underlying challenges. For investors with a higher risk tolerance and a value investing focus, Jocil offers a potential opportunity to capitalise on market mispricing. Nonetheless, the recent downgrade and micro-cap status suggest that caution and active monitoring are essential components of any investment decision involving this stock.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →